(Press-News.org) Radiation-induced brain injury (RIBI) is a serious and often delayed complication of cranial radiotherapy, which remains a cornerstone in the treatment of brain tumors such as gliomas, metastases, and lymphomas. While modern radiotherapy techniques have improved survival rates, they have also led to an increased incidence of RIBI, adversely affecting patients' neurological function and quality of life. This review synthesizes recent advances in multimodal imaging and emerging therapeutic strategies for RIBI, highlighting the shift from conventional symptomatic management to mechanism-driven, precision interventions.
Pathophysiological Mechanisms of RIBI
RIBI is a multifactorial process involving vascular, inflammatory, and cellular damage. Key mechanisms include:
Blood-brain barrier (BBB) disruption: Ionizing radiation damages cerebral microvascular endothelial cells, increasing BBB permeability and allowing inflammatory mediators to infiltrate the brain.
Neuroinflammation: Activation of microglia and astrocytes, along with elevated pro-inflammatory cytokines (e.g., IL-6, IL-1β), contributes to neuronal apoptosis and cognitive decline.
Oxidative stress and DNA damage: Reactive oxygen species (ROS) generation leads to direct and indirect cellular injury, including DNA strand breaks and impaired protein synthesis.
White matter injury: Demyelination and axonal loss disrupt neural signaling, leading to cognitive impairment.
Genetic susceptibility: Polymorphisms in genes such as CEP128 have been linked to individual differences in RIBI risk.
Clinical Manifestations
RIBI progresses through three clinical phases:
Acute phase (hours to weeks): Symptoms include headache, nausea, and somnolence due to cerebral edema.
Subacute phase (1–6 months): Transient cognitive impairment and memory deficits may occur, often with reversible white matter changes.
Late-delayed phase (beyond 6 months): Progressive cognitive decline, executive dysfunction, seizures, and irreversible brain necrosis may develop.
Advances in Multimodal Imaging
Conventional MRI alone is often insufficient for early detection or differentiation of RIBI from tumor recurrence. Multimodal imaging integrates structural, functional, metabolic, and AI-driven analyses to improve diagnostic accuracy:
Structural MRI (T1/T2/FLAIR): Sensitive to white matter lesions and necrosis.
Diffusion imaging (DWI/DTI): Helps differentiate hypercellular tumors (low ADC) from necrosis (high ADC). DTI parameters (e.g., fractional anisotropy) detect microstructural white matter damage.
Perfusion imaging (PWI/ASL/DSC/DCE): Distinguishes hypoperfused radiation necrosis from hyperperfused tumor recurrence.
MRS and PET/CT: Quantify metabolic changes (e.g., choline/NAA ratios) and glucose metabolism to identify necrosis versus recurrence.
Radiomics and AI: Machine learning models extract quantitative imaging features to support non-invasive diagnosis with high accuracy.
Therapeutic Strategies
Current RIBI management is evolving from glucocorticoid-based symptomatic care to targeted and multimodal interventions:
Pharmacotherapy: Bevacizumab (anti-VEGF) is the only treatment validated by randomized trials for radiation necrosis. Corticosteroids reduce edema but have long-term side effects. Sildenafil and simvastatin show neuroprotective potential via anti-inflammatory and antioxidant pathways.
Hyperbaric oxygen (HBO): Promotes angiogenesis and repair, though large-scale trials are lacking.
Stem cell therapy: Mesenchymal and endothelial progenitor cells may support vascular and neural repair, but clinical translation remains experimental.
Neuromodulation: Techniques such as transcranial magnetic stimulation and fMRI neurofeedback offer non-pharmacological options for cognitive rehabilitation.
Gut-brain axis interventions: Probiotics and fecal microbiota transplantation modulate neuroinflammation and cognitive function in preclinical models, representing a novel therapeutic frontier.
Challenges and Future Directions
Despite progress, several challenges persist:
Lack of standardized diagnostic criteria and early biomarkers.
Limited mechanism-driven treatments and high-level evidence for emerging therapies.
Insufficient integration of multimodal imaging into clinical workflows.
Need for interdisciplinary collaboration and large-scale multicenter studies.
Future efforts should focus on:
Establishing consensus diagnostic and grading standards.
Developing predictive models using clinical, imaging, and genetic data.
Advancing targeted therapies against neuroinflammation, oxidative stress, and vascular injury.
Promoting collaborative research to translate preclinical findings into clinical practice.
Conclusion
RIBI remains a significant and complex complication of cranial radiotherapy. Multimodal imaging has enhanced early detection and differential diagnosis, while therapeutic approaches are increasingly targeting underlying pathological mechanisms. However, most treatments are still palliative, and future research must prioritize biomarker discovery, standardized imaging protocols, and rigorous clinical trials to achieve precision management of RIBI.
Full text:
https://xiahepublishing.com/3067-6150/NSSS-2025-00028
The study was recently published in the Neurosurgical Subspecialties.
Neurosurgical Subspecialties (NSSS) is the official scientific journal of the Department of Neurosurgery at Union Hospital of Tongji Medical College, Huazhong University of Science and Technology. NSSS aims to provide a forum for clinicians and scientists in the field, dedicated to publishing high-quality and peer-reviewed original research, reviews, opinions, commentaries, case reports, and letters across all neurosurgical subspecialties. These include but are not limited to traumatic brain injury, spinal and spinal cord neurosurgery, cerebrovascular disease, stereotactic radiosurgery, neuro-oncology, neurocritical care, neurosurgical nursing, neuroendoscopy, pediatric neurosurgery, peripheral neuropathy, and functional neurosurgery.
Follow us on X: @xiahepublishing
Follow us on LinkedIn: Xia & He Publishing Inc.
END
Chronic subdural hematoma (CSDH) is one of the most common neurosurgical conditions, particularly among the elderly, with an annual incidence ranging from 1.7 to 20.6 per 100,000 people. As the global population ages and the use of antiplatelet and anticoagulant therapies increases, the incidence of CSDH is projected to rise significantly. Despite its clinical prevalence, treatment options have seen limited breakthroughs over the past two decades, largely due to an incomplete understanding of its pathophysiology. This review provides a comprehensive overview ...
A Japanese research team has studied the variations in beryllium-7 concentrations in the surface air over the Antarctic regions of Southern Ocean. Beryllium-7 is a radioactive isotope of beryllium produced by cosmic rays in the atmosphere. The team explored, over space and time, how the beryllium-7 is transported from the atmosphere to the Earth’s surface. Their goal was to better understand the mechanisms of atmospheric mixing on Earth.
Their research is published in the Journal of Geophysical Research: Atmospheres on October 14, 2025.
“We aimed to clarify where and by what atmospheric flows the radioactive isotope beryllium-7, produced in the stratosphere ...
SAN ANTONIO — November 18, 2025 — Southwest Research Institute identified a security vulnerability in a standard protocol governing communications between electric vehicles (EV) and EV charging equipment. The research prompted the Cybersecurity & Infrastructure Security Agency (CISA) to issue a security advisory related to the ISO 15118 vehicle-to-grid communications standard.
Through internal research, a team of SwRI engineers spoofed signal measurements between an EV and EV supply equipment (EVSE), leading to CISA’s publication of a Common ...
Operating a new device named the Fusion Z-pinch Experiment 3, or FuZE-3, Zap Energy has now achieved plasmas with electron pressures as high as 830 megapascals (MPa), or 1.6 gigapascals (GPa) total, comparable to the pressures found deep below Earth’s crust. The results are the highest-pressure performance to date in a sheared-flow-stabilized Z pinch and an important marker on the path to scientific energy gain, or Q>1.
FuZE-3 is Zap’s first device to incorporate a third electrode to separate the forces that drive plasma acceleration and compression. Details of the preliminary results were presented today at the American Physical Society’s Division of Plasma ...
Washington, November 18, 2025—Students who enroll in short-term, job-focused training through community college noncredit programs experience modest but meaningful earnings gains and a greater likelihood of being employed after training, according to a new study published today in Educational Evaluation and Policy Analysis, a peer-reviewed journal of the American Educational Research Association.
The study, conducted by Peter Riley Bahr of the Strada Institute for the Future of Work and Rooney Columbus of E&E Analytics, finds that workers earn about $2,000 more per year, on average, within two years of ...
November 18, 2025 – The American Pediatric Society (APS) is pleased to announce Tara O. Henderson, MD, MPH, as the recipient of the 2026 Norman J. Siegel New Member Outstanding Science Award, in recognition of her significant contributions to pediatric science. The award will be presented to Dr. Henderson during the APS Presidential Plenary at the Pediatric Academic Societies 2026 Meeting, taking place in Boston, MA, April 24-27.
Established in honor of renowned nephrologist Norman J. Siegel, MD, FASN, the award celebrates early-career APS members whose scientific work demonstrates ...
Alzheimer’s disease (AD) is a devastating cause of memory loss and cognitive decline, for which no curative treatment is available. Among lifestyle factors, physical activity stands out as possibly one of the strongest defenders of brain health.
Growing evidence links skeletal muscle function to cognitive health. Pioneering research from Florida Atlantic University and its collaborators at the Novo Nordisk Foundation Center for Basic Metabolic Research takes this evidence to the next level, revealing that the key to fighting AD may lie not just in the brain – but also in our muscles.
At the center of this discovery is Cathepsin ...
A study published in Strategic Management Journal sheds light on the subtle yet significant role that unelected officials play in helping corporations secure successful contract bids.
The research, led by Dr. Tony L. He of Rutgers Business School in Newark, N.J., analyzed a dataset of 14,849 public procurement contracts across 28 European countries between 2011 and 2017.
“My research shows that, contrary to what many might expect, in this particular context it’s not the flashy connections to powerful elected officials that help firms most,” Dr. He explained. “Instead, ...
In a Perspective, the authors suggest that the social and humanitarian impacts of overshooting the Paris Agreement’s aspirational goal of a 1.5 degrees Celsius rise in global mean temperature remain largely unknown, despite robust knowledge of physical climate impacts. Andrew Kruczkiewicz and colleagues outline five factors that policymakers and planners should take into account when considering the human impacts of climate overshoot: peak warming and duration of overshoot, localized amplification of effects, timing of arrival, adaptation limits, and dynamics of overshoot reversal. The ...
LOS ANGELES – The 2026 Optical Fiber Communications Conference and Exhibition (OFC), the premier global event for optical communications and networking, will be held 15 – 19 March 2026, at the Los Angeles Convention Center in Los Angeles, California, USA.
The centerpiece of the conference’s technical program is the Plenary Session, which will feature four industry luminaries: Alexis Bjorlin, Senior Vice President and General Manager for DGX Cloud, NVIDIA, USA; Julie Sheridan Eng, Chief Technology Officer, Coherent, USA; Siegbert Martin, Chief ...
